On August 3, 2026, Shell plc repurchased a total of 1,550,000 shares for cancellation across multiple trading venues including LSE, Chi-X, and XAMS. The buy-back is part of Shell's existing share repurchase program announced on July 30, 2026, managed independently by Goldman Sachs International until October 23, 2026. This program follows UK and EU regulations on market abuse and buy-back practices, aiming to return value to shareholders by reducing the number of outstanding shares. The repurchase prices ranged between £33.38 and £33.99 per share in GBP and between €38.93 and €39.76 in EUR.
The FTSE 100 fell 30 points to 10,838, dragged down by AstraZeneca's 9.3% drop following reports of merger talks with Bristol Myers Squibb, which raised concerns over strategic fit and antitrust issues. Commodity giants like Rio Tinto and BP also dec...
On July 31, 2026, Shell plc repurchased a total of 1,530,000 shares for cancellation across different trading venues, including the London Stock Exchange and Euronext Amsterdam. This buyback is part of Shell's existing share repurchase program announ...
The FTSE 100 rose slightly to 10,888 points despite AstraZeneca shares dropping 7% due to merger talks with Bristol Myers Squibb, which face regulatory scrutiny. Shell agreed to sell its European onshore renewables business to TotalEnergies, reflecti...
Shell has agreed to sell its European onshore renewables business, including 500 MW of solar and wind capacity and a 3.5 GW pipeline of projects, to France's TotalEnergies. This move is part of Shell's strategy to reshape its power portfolio by focus...
BP has initiated the sale of its North Sea business as part of a strategic move by new CEO Meg O'Neill to simplify the company's portfolio and prioritize investments in higher-return opportunities. While the North Sea remains vital to the UK's energy...
